EYPT EyePoint, Inc. - Common Stock
$5,96
Kurs · Aug 19, 2026
Fundamentaldaten per Aug 5, 2026
52W-Spanne
$4–$19
13% of range
Analystenbewertung
BUY
20 analysts
Kursziel
$37
+514% upside
P/E (TTM)
-1.9
ROE
-84.0%
Nettogewinnmarge
-739.4%
Über EyePoint, Inc. - Common Stock Unternehmensübersicht von Wikipedia
EyePoint Pharmaceuticals Inc. is a Watertown, Massachusetts company specialising in the application of microelectromechanical systems (MEMS) and nanotechnology to drug delivery.
Mehr lesen
EyePoint Pharmaceuticals Inc. (formerly pSivida Corporation) is a Watertown, Massachusetts company specialising in the application of microelectromechanical systems (MEMS) and nanotechnology to drug delivery.
pSivida obtained porous silicon technology from the British government Defence Evaluation and Research Agency (DERA, now QinetiQ). QinetiQ continues to be a strategic partner.
In June 2004, pSivida acquired full ownership of pSiMedica. In April 2018, pSivida purchased eye products firm Icon Bioscience. Afterwards, it rebranded to its current name of EyepOint Pharmaceuticals, Inc.
Quelle: Wikipedia (Englisch), CC BY-SA 4.0 · Auf Wikipedia ansehen ↗
EYPT Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$5.96
Marktkapitalisierung
$494M
P/E (TTM)
-1.9
EPS (TTM)
$-3.17
Umsatz (TTM)
$31M
Dividendenrendite
—
ROE
-84.0%
Verschuldungsgrad
—
52W-Spanne
$4 – $19
EYPT Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Configure
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz & Nettoergebnis
$31M
2017-06-30
→
2025-12-31
EPS
$-3.17
2017-06-30
→
2025-12-31
Freier Cashflow
$-243M
2019-12-31
→
2025-12-31
Margen
-739.4%
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
Kennzahl
5-Jahres-Trend
EYPT
Peer-Median
P/E (TTM)
-1.9
29.9
P/S (TTM) (K/V (TTM))
15.7
14.4
P/B (K/B)
1.6
4.4
Price / FCF (Kurs / FCF)
-2.0
—
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
Kennzahl
5-Jahres-Trend
EYPT
Peer-Median
Operating Margin (Betriebsgewinnmarge)
-776.0%
—
Net Profit Margin (Nettogewinnmarge)
-739.4%
0.70%
ROA
-59.3%
-0.55%
ROE
-84.0%
-2.5%
ROIC
-79.6%
—
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
Kennzahl
5-Jahres-Trend
EYPT
Peer-Median
Current Ratio (Liquiditätsgrad)
8.9
3.9
Quick Ratio
8.3
—
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Kennzahl
5-Jahres-Trend
EYPT
Peer-Median
Revenue YoY (Umsatz YoY)
-27.5%
—
Revenue CAGR 3Y (Umsatz CAGR 3J)
-8.8%
—
Revenue CAGR 5Y (Umsatz CAGR 5J)
-1.8%
—
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
Kennzahl
5-Jahres-Trend
EYPT
Peer-Median
EYPT Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
KAUF
20 Analysten
- Starker Kauf 7 35,0%
- Kauf 12 60,0%
- Halten 1 5,0%
- Verkauf 0 0,0%
- Starker Verkauf 0 0,0%
12-Monats-Kursziel
13 Analysten · 2026-08-19
Median
$37.00
← Unter allen Zielen
$5.96
Tief
$8.00
Hoch
$68.00
Median-Ziel
$37.00
+520,8%
Mittelwert-Ziel
$36.62
+514,4%
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
-0.07%
| Zeitraum | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|
| 30. Juni 2026 | $-1.09 | $-0.97 | -0.12% |
| 31. März 2026 | $-0.99 | $-0.82 | -0.17% |
| 31. Dezember 2025 | $-0.81 | $-0.76 | -0.05% |
| 30. September 2025 | $-0.85 | $-0.80 | -0.05% |
| 30. Juni 2025 | $-0.85 | $-0.81 | -0.04% |
| 31. März 2025 | $-0.65 | $-0.67 | 0.02% |
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| EYPT | $1.51B | -5.8 | -27.5% | -739.4% | -84.0% | — |
| AQST | $788M | -8.3 | -22.6% | -188.1% | 157.7% | — |
| CTNM | — | -5.3 | — | — | -27.7% | — |
| ZVRA | $509M | 6.6 | 350.9% | 78.2% | 61.2% | — |
| EOLS | $432M | -8.3 | 11.6% | -17.4% | 247.3% | 66.3% |
| RLMD | $354M | -3.3 | 93.7% | — | -112.0% | — |
| BIOA | $495M | -5.9 | — | -896.1% | -28.4% | — |
| AVIR | $279M | -1.8 | — | — | -49.5% | — |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung 16
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $31M | $43M | $46M | $41M | $37M | $34M | $20M | $5M | $8M | $2M | $27M | |
| R&D Expense | $221M | $133M | $65M | $50M | $28M | $17M | $15M | $19M | $15M | $14M | $12M | |
| SG&A Expense | $52M | $52M | $40M | $35M | $26M | $21M | $18M | $15M | $11M | $9M | $8M | |
| Operating Expenses | $275M | $189M | $121M | $141M | $92M | $72M | $68M | $44M | $26M | $23M | $20M | |
| Operating Income | $-243M | $-146M | $-75M | $-100M | $-55M | $-37M | $-48M | $-39M | $-19M | $-22M | $6M | |
| Interest Expense | · | · | $1M | $3M | $5M | $7M | $6M | $2M | $0 | $0 | · | |
| Interest Income | · | · | · | · | · | · | · | · | · | · | $19.0K | |
| Other Non-op | $12M | $15M | $7M | $2M | $292.0K | $58.0K | $1M | $420.0K | $91.0K | $72.0K | $22.0K | |
| Pretax Income | $-232M | $-131M | $-71M | $-102M | $-58M | $-45M | $-57M | · | $-18M | $-22M | $6M | |
| Income Tax | $279.0K | $90.0K | $83.0K | · | $0 | $0 | $0 | · | $0 | $-155.0K | $96.0K | |
| Net Income | $-232M | $-131M | $-71M | $-102M | $-58M | $-45M | $-57M | $-86M | $-18M | $-22M | $6M | |
| EPS (Basic) | $-3.17 | $-2.32 | $-1.82 | $-2.74 | $-2.03 | · | · | · | $-0.52 | $-0.68 | $0.22 | |
| EPS (Diluted) | $-3.17 | $-2.32 | $-1.82 | $-2.74 | $-2.03 | · | · | · | $-0.52 | $-0.68 | $0.21 | |
| Shares (Basic) | 73,251 | 56,298 | 38,904 | 37,317,000 | 28,758,000 | · | · | · | 35,343,765 | 31,623,473 | 29,378,250 | |
| Shares (Diluted) | 73,251 | 56,298 | 38,904 | 37,317,000 | 28,758,000 | · | · | · | 35,343,765 | 31,623,473 | 30,584,140 | |
| EBITDA | $-241M | $-146M | $-75M | $-100M | $-55M | · | $-48M | · | · | $-22M | $6M |
Bilanz 27
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $102M | $100M | $281M | $96M | $179M | $45M | $22M | $45M | $17M | $15M | $19M | |
| Short-term Investments | $204M | $271M | $50M | $49M | $33M | $0 | $0 | $0 | $0 | $14M | $9M | |
| Inventory | $2M | $2M | $4M | $3M | $4M | $5M | $2M | $279.0K | · | · | · | |
| Prepaid Expense | $20M | $9M | $9M | $10M | $4M | $3M | $6M | $1M | $591.0K | $483.0K | $681.0K | |
| Other Current Assets | $2M | $1M | $1M | $782.0K | $517.0K | · | · | · | · | · | · | |
| Current Assets | $329M | $383M | $345M | $173M | $238M | $63M | $42M | $48M | $18M | $30M | $30M | |
| PP&E (Net) | $9M | $8M | $5M | $1M | $476.0K | $630.0K | $357.0K | $288.0K | $313.0K | $290.0K | $338.0K | |
| PP&E (Gross) | $15M | $12M | $8M | $3M | $2M | $2M | $1M | $983.0K | $799.0K | $2M | $2M | |
| Accum. Depreciation | $6M | $4M | $3M | $2M | $1M | $1M | $839.0K | $695.0K | $486.0K | $2M | $2M | |
| Intangibles | · | · | · | $0 | $23M | $25M | $28M | $30M | $364.0K | $1M | $2M | |
| Other Non-current Assets | $6M | $6M | $0 | · | · | · | · | · | · | · | · | |
| Total Assets | $364M | $418M | $355M | $180M | $263M | $92M | $73M | $78M | $19M | $32M | $32M | |
| Accounts Payable | $10M | $12M | $7M | $6M | $7M | $5M | $4M | $3M | $1M | $1M | $744.0K | |
| Accrued Liabilities | $24M | $18M | $18M | $16M | $14M | $8M | $7M | $4M | $4M | $4M | $3M | |
| Short-term Debt | · | · | $0 | $10M | $0 | · | · | · | · | · | · | |
| Current Liabilities | $37M | $49M | $63M | $35M | $24M | $15M | $12M | $21M | $5M | $5M | $3M | |
| Capital Leases | $21M | $22M | $5M | $6M | $2M | $2M | $3M | $0 | · | · | · | |
| Other Non-current Liabilities | $87.0K | $205.0K | $0 | $600.0K | $2M | $2M | $3M | $1M | $51.0K | · | · | |
| Total Liabilities | $58M | $82M | $89M | $84M | $79M | $73M | $65M | $41M | $5M | $11M | $9M | |
| Long-term Debt | · | · | · | $30M | · | · | · | · | · | · | · | |
| Total Debt | · | · | $0 | $40M | $37M | · | $47M | · | · | · | · | |
| Common Stock | $83.0K | $68.0K | $49.0K | $34.0K | $34.0K | $18.0K | $11.0K | $95.0K | $39.0K | $34.0K | $29.0K | |
| Retained Earnings | $-1.10B | $-873M | $-742M | $-671M | $-569M | $-511M | $-465M | $-408M | $-311M | $-292M | $-271M | |
| AOCI | $961.0K | $1M | $864.0K | $786.0K | $841.0K | $841.0K | $840.0K | $839.0K | $833.0K | $852.0K | $945.0K | |
| Stockholders' Equity | $306M | $337M | $266M | $96M | $184M | $19M | $8M | $38M | $13M | $21M | $23M | |
| Liabilities + Equity | $364M | $418M | $355M | $180M | $263M | $92M | $73M | $78M | $19M | $32M | $32M | |
| Shares Outstanding | 82,826,416 | 68,266,005 | 49,043,074 | 34,082,934 | 33,905,826 | 18,139,981 | 10,941,659 | 95,372,236 | 39,356,999 | 34,172,919 | 29,412,365 |
Cashflow 18
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $2M | $2M | $464.0K | · | · | · | · | · | · | · | · | |
| Stock-based Comp | $28M | $37M | $12M | $14M | $7M | $6M | $5M | · | $2M | $2M | $2M | |
| Deferred Tax | $279.0K | $90.0K | $83.0K | · | · | · | · | · | · | · | · | |
| Amort. of Intangibles | · | · | $0 | $2M | $2M | $2M | $2M | $981.0K | $724.0K | $756.0K | $770.0K | |
| Restructuring | · | · | · | · | · | $590.0K | · | · | $472.0K | · | · | |
| Other Non-cash | $-39M | · | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-240M | $-126M | $2M | $-65M | $-50M | $-14M | $-57M | · | $-20M | $-16M | $10M | |
| CapEx | $3M | $4M | $3M | $2M | $156.0K | $362.0K | $213.0K | · | $147.0K | $113.0K | $161.0K | |
| Investing Cash Flow | $69M | $-219M | $-3M | $-17M | $-33M | $-362.0K | $-213.0K | · | $14M | $-4M | · | |
| Debt Issued | · | · | $0 | $30M | $0 | · | $50M | · | $0 | $0 | · | |
| Net Debt Issued | · | $0 | $-30M | $-8M | $0 | · | $30M | · | · | · | · | |
| Stock Issued | $173M | $163M | $226M | $0 | · | $50M | $23M | · | $8M | $16M | $0 | |
| Net Stock Activity | $173M | $163M | $226M | · | · | · | $23M | · | · | $16M | · | |
| Financing Cash Flow | $174M | $164M | $187M | $-690.0K | $217M | $37M | $34M | · | $9M | $17M | · | |
| Net Change in Cash | $2M | $-182M | $186M | $-83M | $134M | $23M | $-23M | · | $2M | $-4M | $4M | |
| Taxes Paid | $200.0K | $100.0K | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $-243M | $-130M | $-2M | $-67M | $-50M | · | $-57M | · | · | $-16M | $10M | |
| Levered FCF | · | · | $-3M | $-70M | $-56M | · | $-63M | · | · | · | · |
Rentabilität 7
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -776.0% | -337.1% | -163.1% | -240.6% | -149.6% | · | -235.0% | · | · | -1344.1% | 24.2% | |
| Net Margin | -739.4% | -302.4% | -153.8% | -247.0% | -158.1% | · | -278.9% | · | · | -1330.1% | 23.9% | |
| Pretax Margin | -738.5% | -302.2% | -153.7% | -247.0% | -158.1% | · | -278.9% | · | · | -1339.6% | 24.2% | |
| EBITDA Margin | -768.6% | -337.1% | -163.1% | -240.6% | -149.6% | · | -235.0% | · | · | -1344.1% | 24.2% | |
| ROA | -59.3% | -33.8% | -26.4% | -46.1% | -32.9% | · | -75.1% | · | · | -67.3% | 23.1% | |
| ROE | -84.0% | -47.1% | -43.6% | -87.9% | -42.2% | · | -468.1% | · | · | -90.8% | 24.8% | |
| ROIC | -79.6% | -43.4% | -28.2% | -73.2% | -25.0% | · | -86.2% | · | · | -103.5% | 27.1% |
Liquidität & Solvenz 5
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 8.9 | 7.8 | 5.5 | 5.0 | 10.0 | · | 3.6 | · | · | 5.9 | 8.9 | |
| Quick Ratio | 8.3 | 7.6 | 5.2 | 4.2 | 8.9 | · | 1.9 | · | · | 5.7 | 8.5 | |
| Debt / Equity | · | · | 0.0 | 0.4 | 0.2 | · | 5.7 | · | · | · | · | |
| LT Debt / Equity | · | · | · | 0.3 | 0.2 | · | 5.7 | · | · | · | · | |
| Interest Coverage | · | · | -60.2 | -31.2 | -10.1 | · | -7.7 | · | · | · | · |
Effizienz 1
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | 0.2 | 0.2 | 0.2 | · | 0.3 | · | · | 0.1 | 1.0 |
Wachstumsraten 3
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -27.5% | -6.0% | 11.1% | 12.1% | 7.3% | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -8.8% | 5.4% | 10.2% | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | -1.8% | · | · | · | · | · | · | · | · | · | · |
Bewertung (TTM) 14
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $31M | $43M | $46M | $41M | $37M | $34M | $20M | · | $8M | $2M | $27M | |
| Net Income TTM | $-232M | $-131M | $-71M | $-102M | $-58M | $-45M | $-57M | · | $-18M | $-22M | $6M | |
| Market Cap | $1.51B | $509M | $1.13B | $119M | $415M | · | $1.70B | · | · | $967M | $1.11B | |
| Enterprise Value | · | · | $802M | $15M | $240M | · | $1.72B | · | · | · | · | |
| P/E | -5.8 | -3.2 | -12.7 | -1.3 | -6.0 | -9.8 | -23.1 | · | -32.9 | -41.6 | 179.5 | |
| P/S | 48.2 | 11.8 | 24.6 | 2.9 | 11.2 | · | 83.3 | · | · | 597.0 | 41.7 | |
| P/B | 4.9 | 1.5 | 4.3 | 1.2 | 2.3 | · | 203.6 | · | · | 46.3 | 47.5 | |
| P / Tangible Book | 4.9 | 1.5 | 4.3 | 1.2 | 2.6 | · | · | · | · | · | · | |
| P / Cash Flow | -6.3 | -4.0 | 604.5 | -1.8 | -8.3 | · | -29.9 | · | · | -59.3 | 107.7 | |
| P / FCF | -6.2 | -3.9 | -704.8 | -1.8 | -8.3 | · | -29.8 | · | · | -58.9 | 109.4 | |
| EV / EBITDA | · | · | -10.7 | -0.1 | -4.3 | · | -36.0 | · | · | · | · | |
| EV / FCF | · | · | -499.0 | -0.2 | -4.8 | · | -30.2 | · | · | · | · | |
| EV / Revenue | · | · | 17.4 | 0.4 | 6.5 | · | 84.5 | · | · | · | · | |
| Earnings Yield | -17.3% | -31.1% | -7.9% | -78.3% | -16.6% | -10.2% | -4.3% | · | -3.0% | -2.4% | 0.56% |
Gewinn- und Verlustrechnung 16
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $507.0K | $696.0K | $619.0K | $966.0K | $5M | $24M | $12M | $11M | $9M | $12M | $14M | $15M | $9M | $8M | $11M | $10M | |
| Cost of Revenue | · | · | · | · | · | · | · | $736.0K | $1M | $759.0K | · | $1M | $2M | $640.0K | · | · | |
| R&D Expense | $84M | $72M | $59M | $48M | $55M | $59M | $43M | $30M | $30M | $30M | $18M | $17M | $16M | $14M | $16M | $11M | |
| SG&A Expense | $14M | $15M | $11M | $14M | $12M | $14M | $13M | $13M | $13M | $14M | $11M | $11M | $9M | $9M | $8M | $9M | |
| Operating Expenses | $98M | $88M | $71M | $63M | $68M | $73M | $57M | $43M | $44M | $45M | $30M | $30M | $32M | $29M | $54M | $28M | |
| Operating Income | $-97M | $-87M | $-70M | $-62M | $-62M | $-49M | $-45M | $-33M | $-35M | $-33M | $-16M | $-14M | $-23M | $-22M | $-44M | $-18M | |
| Interest Expense | · | · | · | · | · | · | · | · | $0 | $0 | · | $0 | $435.0K | $812.0K | $781.0K | $662.0K | |
| Other Non-op | $3M | $2M | $3M | $2M | $3M | $4M | $4M | $3M | $4M | $4M | $2M | $2M | $2M | $1M | $1M | $640.0K | |
| Pretax Income | $-94M | · | $-67M | $-60M | $-59M | · | $-41M | $-29M | $-31M | · | · | · | · | · | · | · | |
| Income Tax | $0 | $-50.0K | $186.0K | $0 | $93.0K | $0 | $90.0K | $0 | $0 | · | · | · | · | · | · | · | |
| Net Income | $-94M | $-85M | $-68M | $-60M | $-59M | $-45M | $-41M | $-29M | $-31M | $-29M | $-14M | $-13M | $-23M | $-21M | $-43M | $-18M | |
| EPS (Basic) | $-1.09 | $-0.99 | $-0.82 | $-0.85 | $-0.85 | $-0.65 | $-0.65 | $-0.54 | $-0.58 | $-0.55 | $-0.32 | $-0.33 | $-0.61 | $-0.56 | $-1.17 | $-0.49 | |
| EPS (Diluted) | $-1.09 | $-0.99 | $-0.82 | $-0.85 | $-0.85 | $-0.65 | $-0.65 | $-0.54 | $-0.58 | $-0.55 | $-0.32 | $-0.33 | $-0.61 | $-0.56 | $-1.17 | $-0.49 | |
| Shares (Basic) | 86,543 | 85,999 | -69,833,843 | 70,168 | 69,926 | 69,767 | -52,964,357 | 54,449 | 53,206 | 52,913,000 | -75,915,582 | 38,341,000 | 37,576,000 | 37,486 | -74,596,000 | 37,338,000 | |
| Shares (Diluted) | 86,543 | 85,999 | -69,833,843 | 70,168 | 69,926 | 69,767 | -52,964,357 | 54,449 | 53,206 | 52,913,000 | -75,915,582 | 38,341,000 | 37,576,000 | 37,486 | -74,596,000 | 37,338,000 | |
| EBITDA | $-97M | $-87M | · | $-62M | $-62M | $-49M | · | $-33M | $-35M | $-33M | · | $-14M | $-23M | $-22M | · | $-18M |
Bilanz 27
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $110M | $78M | $102M | $75M | $71M | $85M | $100M | $80M | $91M | $271M | $281M | $133M | $140M | $106M | $96M | $75M | |
| Short-term Investments | $70M | $145M | $204M | $129M | $185M | $233M | $271M | $174M | $189M | $28M | $50M | $3M | $3M | $17M | $49M | $82M | |
| Inventory | $2M | $1M | $2M | $2M | $3M | $2M | $2M | $3M | $4M | $4M | $4M | $5M | $4M | $4M | $3M | $4M | |
| Prepaid Expense | $6M | $25M | $20M | $9M | $6M | $6M | $9M | $12M | $10M | $11M | $9M | $9M | $9M | $9M | $10M | $10M | |
| Other Current Assets | $987.0K | $1M | $2M | $899.0K | $2M | $1M | $1M | $1M | $1M | $1M | $1M | $549.0K | $0 | $0 | $782.0K | · | |
| Current Assets | $189M | $250M | $329M | $216M | $265M | $327M | $383M | $269M | $295M | $318M | $345M | $150M | $167M | $146M | $173M | $192M | |
| PP&E (Net) | $10M | $9M | $9M | $9M | $9M | $8M | $8M | $8M | $7M | $7M | $5M | $4M | $3M | $3M | $1M | $1M | |
| PP&E (Gross) | · | · | $15M | · | · | · | $12M | · | · | · | $8M | · | · | · | $3M | · | |
| Accum. Depreciation | · | · | $6M | · | · | · | $4M | · | · | · | $3M | · | · | · | $2M | · | |
| Intangibles | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $21M | |
| Other Non-current Assets | $9M | $9M | $6M | $6M | $6M | $6M | $6M | $2M | · | · | $0 | · | · | · | · | · | |
| Total Assets | $228M | $288M | $364M | $252M | $301M | $363M | $418M | $301M | $324M | $329M | $355M | $160M | $176M | $155M | $180M | $220M | |
| Accounts Payable | $17M | $19M | $10M | $10M | $20M | $16M | $12M | $7M | $14M | $7M | $7M | $10M | $11M | $9M | $6M | $6M | |
| Accrued Liabilities | $22M | $16M | $24M | $18M | $11M | $18M | $18M | $14M | $13M | $16M | $18M | $13M | $15M | $10M | $16M | $16M | |
| Short-term Debt | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $5M | $10M | $10M | |
| Current Liabilities | $42M | $37M | $37M | $30M | $33M | $42M | $49M | $49M | $62M | $63M | $63M | $64M | $69M | $27M | $35M | $34M | |
| Capital Leases | $20M | $20M | $21M | $21M | $22M | $22M | $22M | $22M | $22M | $5M | $5M | $5M | $5M | $6M | $6M | $6M | |
| Other Non-current Liabilities | $23.0K | $55.0K | $87.0K | $118.0K | $148.0K | $177.0K | $205.0K | $233.0K | · | · | $0 | $0 | $0 | $600.0K | $600.0K | $600.0K | |
| Total Liabilities | $62M | $58M | $58M | $52M | $55M | $64M | $82M | $82M | $96M | $79M | $89M | $101M | $118M | $76M | $84M | $84M | |
| Long-term Debt | · | · | · | · | · | · | · | · | · | · | · | · | · | $30M | · | $30M | |
| Total Debt | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $35M | · | $40M | |
| Common Stock | $85.0K | $83.0K | $83.0K | $70.0K | $69.0K | $69.0K | $68.0K | $53.0K | $52.0K | $50.0K | $49.0K | $35.0K | $34.0K | $34.0K | $34.0K | $34.0K | |
| Retained Earnings | $-1.28B | $-1.19B | $-1.10B | $-1.04B | $-978M | $-918M | $-873M | $-832M | $-802M | $-771M | $-742M | $-728M | $-715M | $-693M | $-671M | $-628M | |
| AOCI | $793.0K | $802.0K | $961.0K | $919.0K | $832.0K | $923.0K | $1M | $1M | $792.0K | $836.0K | $864.0K | $841.0K | $842.0K | $843.0K | $786.0K | $653.0K | |
| Stockholders' Equity | $166M | $230M | $306M | $200M | $246M | $298M | $337M | $219M | $228M | $250M | $266M | $59M | $57M | $78M | $96M | $136M | |
| Liabilities + Equity | $228M | $288M | $364M | $252M | $301M | $363M | $418M | $301M | $324M | $329M | $355M | $160M | $176M | $155M | $180M | $220M | |
| Shares Outstanding | 84,981,843 | 83,453,001 | 82,826,416 | 69,569,813 | 68,889,649 | 68,811,357 | 68,266,005 | 53,524,364 | 52,160,305 | 49,885,701 | 49,043,074 | 35,309,432 | 34,306,118 | 34,301,926 | 34,082,934 | 34,072,155 |
Cashflow 14
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $690.0K | $636.0K | $698.0K | $576.0K | $538.0K | $497.0K | $467.0K | $408.0K | $362.0K | $303.0K | $112.0K | · | · | · | · | · | |
| Stock-based Comp | $10M | $12M | $7M | $6M | $7M | $8M | $8M | $7M | $9M | $13M | $4M | $4M | $2M | $3M | $3M | $3M | |
| Deferred Tax | · | · | $369.0K | $0 | · | · | $90.0K | $0 | · | · | · | · | · | · | · | · | |
| Amort. of Intangibles | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | $205.0K | $615.0K | |
| Other Non-cash | · | $-8M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-62M | $-81M | $-65M | $-59M | $-63M | $-53M | $-36M | $-39M | $-20M | $-31M | $-23M | $-15M | $57M | $-17M | $-13M | $-13M | |
| CapEx | $1M | $997.0K | $986.0K | $798.0K | $1M | $276.0K | $384.0K | $2M | $900.0K | $1M | $883.0K | $2M | $396.0K | $484.0K | $585.0K | $1M | |
| Investing Cash Flow | $75M | $59M | $-75M | $55M | $48M | $40M | $-96M | $16M | $-160M | $21M | $-47M | $-2M | $13M | $32M | $33M | $6M | |
| Debt Issued | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | $0 | $0 | |
| Net Debt Issued | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | · | · | |
| Stock Issued | · | · | $167M | $7M | · | · | $152M | · | · | · | $216M | · | · | · | $0 | · | |
| Financing Cash Flow | $20M | $-3M | $167M | $7M | $238.0K | $-951.0K | $152M | $12M | $329.0K | $115.0K | $218M | $10M | $-37M | $-5M | $-58.0K | $92.0K | |
| Net Change in Cash | $33M | $-24M | $27M | $3M | $-14M | $-15M | $20M | $-11M | $-180M | $-10M | $148M | $-7M | $34M | $10M | $20M | $-7M | |
| Free Cash Flow | · | $-82M | · | · | · | $-53M | · | · | · | $-32M | · | · | · | $-17M | · | · |
Rentabilität 7
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -19207.1% | -12532.5% | · | -6420.8% | -1166.8% | -199.7% | · | -311.2% | -364.5% | -285.2% | · | -94.7% | -250.0% | -280.5% | · | -183.8% | |
| Net Margin | -18633.1% | -12188.5% | · | -6183.4% | -1114.3% | -184.8% | · | -279.0% | -325.3% | -250.6% | · | -83.0% | -251.7% | -275.5% | · | -184.0% | |
| Pretax Margin | -18633.1% | · | · | -6183.4% | -1112.6% | · | · | · | · | · | · | · | · | · | · | · | |
| EBITDA Margin | -19207.1% | -12441.1% | · | -6420.8% | -1166.8% | -199.7% | · | -311.2% | -364.5% | -285.2% | · | -94.7% | -250.0% | -280.5% | · | -183.8% | |
| ROA | -35.7% | -26.1% | · | -21.6% | -19.0% | -13.1% | · | -12.7% | -12.3% | -12.1% | · | -6.6% | -11.2% | -10.6% | · | -9.5% | |
| ROE | -45.8% | -32.1% | · | -28.5% | -25.1% | -16.5% | · | -21.2% | -21.6% | -17.8% | · | -12.9% | -22.0% | -17.3% | · | -16.1% | |
| ROIC | -58.5% | · | · | -31.0% | -25.3% | · | · | · | · | · | · | · | · | · | · | · |
Liquidität & Solvenz 5
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.5 | 6.7 | · | 7.2 | 8.0 | 7.8 | · | 5.5 | 4.7 | 5.1 | · | 2.4 | 2.4 | 5.4 | · | 5.6 | |
| Quick Ratio | 4.3 | 5.9 | · | 6.8 | 7.7 | 7.6 | · | 5.2 | 4.5 | 4.8 | · | 2.1 | 2.1 | 4.5 | · | 4.6 | |
| Debt / Equity | · | · | · | · | · | · | · | · | · | · | · | 0.0 | 0.0 | 0.4 | · | 0.3 | |
| LT Debt / Equity | · | · | · | · | · | · | · | · | · | · | · | 0.0 | 0.0 | 0.4 | · | 0.2 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | · | · | · | -52.3 | -26.5 | · | -27.8 |
Effizienz 2
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.1 | · | 0.0 | 0.0 | 0.0 | · | 0.1 | 0.0 | 0.0 | · | 0.1 | |
| Inventory Turnover | · | · | · | · | · | · | · | 0.2 | 0.4 | 0.2 | · | · | · | · | · | · |
Bewertung (TTM) 14
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $8M | $31M | · | $41M | $50M | $56M | · | $47M | $45M | $44M | · | $42M | $38M | $39M | · | $40M | |
| Net Income TTM | $-298M | $-249M | · | $-194M | $-165M | $-135M | · | $-102M | $-96M | $-86M | · | $-75M | $-82M | $-80M | · | $-75M | |
| Market Cap | $1.22B | $1.08B | · | $991M | $648M | $373M | · | $428M | $454M | $1.03B | · | $282M | $298M | $101M | · | $270M | |
| Enterprise Value | · | · | · | · | · | · | · | · | · | · | · | $146M | $156M | $13M | · | $152M | |
| P/E | -3.8 | -3.9 | · | -4.9 | -3.6 | -2.3 | · | -4.0 | -4.2 | -10.1 | · | -4.0 | -4.0 | -1.4 | · | -3.7 | |
| P/S | 162.0 | 34.2 | · | 24.0 | 13.0 | 6.6 | · | 9.1 | 10.0 | 23.6 | · | 6.7 | 7.8 | 2.6 | · | 6.7 | |
| P/B | 7.3 | 4.7 | · | 4.9 | 2.6 | 1.2 | · | 2.0 | 2.0 | 4.1 | · | 4.8 | 5.2 | 1.3 | · | 2.0 | |
| P / Tangible Book | 7.3 | 4.7 | · | 4.9 | 2.6 | 1.2 | · | 2.0 | 2.0 | 4.1 | · | 4.8 | 5.2 | 1.3 | · | 2.3 | |
| P / Cash Flow | · | -13.4 | · | · | · | -7.0 | · | · | · | -33.1 | · | · | · | -6.0 | · | · | |
| P / FCF | · | -13.2 | · | · | · | -7.0 | · | · | · | -31.9 | · | · | · | -5.8 | · | · | |
| EV / EBITDA | · | · | · | · | · | · | · | · | · | · | · | -10.1 | -6.9 | -0.6 | · | -8.3 | |
| EV / FCF | · | · | · | · | · | · | · | · | · | · | · | · | · | -0.8 | · | · | |
| EV / Revenue | · | · | · | · | · | · | · | · | · | · | · | 3.5 | 4.1 | 0.3 | · | 3.8 | |
| Earnings Yield | -26.4% | -25.9% | · | -20.3% | -27.8% | -42.8% | · | -25.0% | -23.8% | -9.9% | · | -24.9% | -25.1% | -72.5% | · | -27.2% |
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
Gewinn- und Verlustrechnung
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Umsatz | $31M | $43M | $46M | $41M | $37M |
| Betriebsgewinnmarge % | -776.0% | -337.1% | -163.1% | -240.6% | -149.6% |
| Nettoergebnis | $-232M | $-131M | $-71M | $-102M | $-58M |
| Verwässerte EPS | $-3.17 | $-2.32 | $-1.82 | $-2.74 | $-2.03 |
Bilanz
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital | — | — | 0.0 | 0.4 | 0.2 |
| Liquiditätsgrad | 8.9 | 7.8 | 5.5 | 5.0 | 10.0 |
| Quick Ratio | 8.3 | 7.6 | 5.2 | 4.2 | 8.9 |
Cashflow
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Freier Cashflow | $-243M | $-130M | $-2M | $-67M | $-50M |
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
📊
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das ➕ neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Institutionelle Eigentümer (13F) 217 Einreicher · $1.2B gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 37 (-25 vs. Vorquartal) | 21 (-2 vs. Vorquartal) | 63 (-9 vs. Vorquartal) | 56 (+18 vs. Vorquartal) | +3.1M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| MONTANOVA CAPITAL, LLC | $118.638.163 | 8.296.375 | 10,19% | Aktien |
| Cormorant Asset Management, LP | $100.100.000 | 7.000.000 | 8,60% | Aktien |
| VANGUARD GROUP INC | $78.353.343 | 4.288.634 | 6,73% | Aktien |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $69.037.426 | 4.827.792 | 5,93% | Aktien |
| Commodore Capital LP | $65.780.000 | 4.600.000 | 5,65% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $51.912.604 | 3.630.252 | 4,46% | Aktien |
| JANUS HENDERSON GROUP PLC | $45.962.750 | 3.565.768 | 3,95% | Aktien |
| Paradigm Biocapital Advisors LP | $41.332.677 | 2.890.397 | 3,55% | Aktien |
| STATE STREET CORP | $33.712.894 | 2.357.545 | 2,90% | Aktien |
| Aberdeen Group plc | $28.725.869 | 2.008.802 | 2,47% | Aktien |
| PERCEPTIVE ADVISORS LLC | $28.600.000 | 2.000.000 | 2,46% | Verkaufsoption |
| Balyasny Asset Management L.P. | $25.916.719 | 1.812.358 | 2,23% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $25.269.659 | 1.766.745 | 2,17% | Aktien |
| CITADEL ADVISORS LLC | $25.214.389 | 1.763.244 | 2,17% | Aktien |
| Parkman Healthcare Partners LLC | $18.420.731 | 1.288.163 | 1,58% | Aktien |
| EVENTIDE ASSET MANAGEMENT, LLC | $17.811.837 | 1.245.583 | 1,53% | Aktien |
| TWO SIGMA INVESTMENTS, LP | $16.890.345 | 1.181.143 | 1,45% | Aktien |
| Essex Woodlands Management, Inc. | $15.513.455 | 1.084.857 | 1,33% | Aktien |
| ORBIMED ADVISORS LLC | $15.288.802 | 1.069.147 | 1,31% | Aktien |
| 5AM Venture Management, LLC | $15.015.000 | 1.050.000 | 1,29% | Aktien |
| Rosalind Advisors, Inc. | $14.131.689 | 988.230 | 1,21% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $13.885.500 | 971.014 | 1,19% | Aktien |
| HSBC HOLDINGS PLC | $11.918.407 | 833.455 | 1,02% | Aktien |
| Candriam S.C.A. | $11.254.258 | 787.769 | 0,97% | Aktien |
| AMERIPRISE FINANCIAL INC | $11.087.640 | 775.357 | 0,95% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $11.062.981 | 773.635 | 0,95% | Aktien |
| Artia Global Partners LP | $10.969.501 | 767.098 | 0,94% | Aktien |
| Blue Owl Capital Holdings LP | $10.905.094 | 762.594 | 0,94% | Aktien |
| Patient Square Capital LP | $10.296.000 | 720.000 | 0,88% | Aktien |
| Principia Wealth Advisory, LLC | $9.696.346 | 530.725 | 0,83% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $9.260.866 | 647.613 | 0,80% | Aktien |
| Sio Capital Management, LLC | $8.910.759 | 623.130 | 0,77% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $7.996.789 | 559.216 | 0,69% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $7.899.320 | 552.400 | 0,68% | Kaufoption |
| Alyeska Investment Group, L.P. | $7.284.463 | 509.403 | 0,63% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $7.151.330 | 500.093 | 0,61% | Aktien |
| Simplify Asset Management Inc. | $5.720.629 | 400.044 | 0,49% | Aktien |
| Ikarian Capital, LLC | $5.296.720 | 370.400 | 0,46% | Kaufoption |
| Ikarian Capital, LLC | $5.296.720 | 370.400 | 0,46% | Verkaufsoption |
| Ghisallo Capital Management LLC | $5.005.000 | 350.000 | 0,43% | Aktien |
| STEMPOINT CAPITAL LP | $4.840.135 | 338.471 | 0,42% | Aktien |
| E Fund Management Co., Ltd. | $4.730.068 | 330.774 | 0,41% | Aktien |
| Jump Financial, LLC | $4.586.825 | 320.757 | 0,39% | Aktien |
| Bleichroeder LP | $4.526.165 | 316.515 | 0,39% | Aktien |
| Woodline Partners LP | $4.296.621 | 300.463 | 0,37% | Aktien |
| Eversept Partners, LP | $4.257.610 | 297.735 | 0,37% | Aktien |
| GOLDMAN SACHS GROUP INC | $4.086.797 | 285.790 | 0,35% | Aktien |
| Rock Springs Capital Management LP | $3.839.822 | 268.519 | 0,33% | Aktien |
| CITIGROUP INC | $3.750.032 | 262.240 | 0,32% | Aktien |
| MYDA Advisors LLC | $3.575.000 | 250.000 | 0,31% | Aktien |
| AXA Investment Managers S.A. | $3.480.640 | 244.427 | 0,30% | Aktien |
| UBS Group AG | $3.373.442 | 235.905 | 0,29% | Aktien |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | $3.342.639 | 233.751 | 0,29% | Aktien |
| Schonfeld Strategic Advisors LLC | $3.285.853 | 229.780 | 0,28% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $3.038.750 | 212.500 | 0,26% | Verkaufsoption |
| Propel Bio Management, LLC | $2.741.954 | 191.745 | 0,24% | Aktien |
| Qube Research & Technologies Ltd | $2.704.159 | 189.102 | 0,23% | Aktien |
| Walleye Capital LLC | $2.691.560 | 188.221 | 0,23% | Aktien |
| Susquehanna Portfolio Strategies, LLC | $2.685.554 | 187.801 | 0,23% | Aktien |
| BlackRock, Inc. | $2.649.890 | 185.307 | 0,23% | Aktien |
| CITADEL ADVISORS LLC | $2.559.700 | 179.000 | 0,22% | Verkaufsoption |
| SCHRODER INVESTMENT MANAGEMENT GROUP | $2.389.303 | 169.334 | 0,21% | Aktien |
| HighVista Strategies LLC | $2.226.567 | 155.704 | 0,19% | Aktien |
| Granahan Investment Management, LLC | $2.136.234 | 149.387 | 0,18% | Aktien |
| Swiss National Bank | $2.034.890 | 142.300 | 0,17% | Aktien |
| STATE OF WISCONSIN INVESTMENT BOARD | $1.998.711 | 139.770 | 0,17% | Aktien |
| PANAGORA ASSET MANAGEMENT INC | $1.890.660 | 132.214 | 0,16% | Aktien |
| Corient Private Wealth LP | $1.827.526 | 127.799 | 0,16% | Aktien |
| ESSEX INVESTMENT MANAGEMENT CO LLC | $1.740.081 | 121.684 | 0,15% | Aktien |
| BOOTHBAY FUND MANAGEMENT, LLC | $1.548.690 | 108.300 | 0,13% | Kaufoption |
| BOOTHBAY FUND MANAGEMENT, LLC | $1.548.690 | 108.300 | 0,13% | Verkaufsoption |
| DIADEMA PARTNERS LP | $1.520.090 | 106.300 | 0,13% | Kaufoption |
| SILVERBACK ASSET MANAGEMENT LLC | $1.430.000 | 100.000 | 0,12% | Kaufoption |
| Squarepoint Ops LLC | $1.401.429 | 98.002 | 0,12% | Aktien |
| RHUMBLINE ADVISERS | $1.393.341 | 97.437 | 0,12% | Aktien |
| CITADEL ADVISORS LLC | $1.357.070 | 94.900 | 0,12% | Kaufoption |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $1.354.752 | 105.101 | 0,12% | Aktien |
| ALGERT GLOBAL LLC | $1.129.557 | 78.990 | 0,10% | Aktien |
| Waverly Advisors, LLC | $1.114.170 | 77.914 | 0,10% | Aktien |
| Cinctive Capital Management LP | $1.037.923 | 72.582 | 0,09% | Aktien |
| Caption Management, LLC | $1.036.750 | 72.500 | 0,09% | Kaufoption |
| WELLINGTON MANAGEMENT GROUP LLP | $1.035.134 | 72.387 | 0,09% | Aktien |
| GOLDMAN SACHS GROUP INC | $1.002.430 | 70.100 | 0,09% | Kaufoption |
| DEUTSCHE BANK AG\ | $989.860 | 69.221 | 0,09% | Aktien |
| Bank of New York Mellon Corp | $981.824 | 68.659 | 0,08% | Aktien |
| WOODSTOCK CORP | $979.049 | 68.465 | 0,08% | Aktien |
| ALLIANCEBERNSTEIN L.P. | $971.081 | 75.336 | 0,08% | Aktien |
| BANK OF AMERICA CORP /DE/ | $930.186 | 65.048 | 0,08% | Aktien |
| Zurcher Kantonalbank (Zurich Cantonalbank) | $865.708 | 60.539 | 0,07% | Aktien |
| FOX RUN MANAGEMENT, L.L.C. | $836.950 | 58.528 | 0,07% | Aktien |
| Y-Intercept (Hong Kong) Ltd | $732.017 | 51.190 | 0,06% | Aktien |
| SILVERBACK ASSET MANAGEMENT LLC | $715.000 | 50.000 | 0,06% | Aktien |
| JANE STREET GROUP, LLC | $715.000 | 50.000 | 0,06% | Kaufoption |
| Erste Asset Management GmbH | $705.500 | 50.000 | 0,06% | Aktien |
| VANGUARD ASSET MANAGEMENT, Ltd | $702.545 | 49.129 | 0,06% | Aktien |
| Point72 Asset Management, L.P. | $694.608 | 48.574 | 0,06% | Aktien |
| SBI Okasan Asset Management Co.Ltd. | $644.827 | 45.700 | 0,06% | Aktien |
| MetLife Investment Management, LLC | $621.607 | 43.469 | 0,05% | Aktien |
| JANE STREET GROUP, LLC | $597.954 | 41.815 | 0,05% | Aktien |
| SCOTIA CAPITAL INC. | $597.039 | 41.751 | 0,05% | Aktien |
Unternehmensinsider 25 Insider · 12 Führungskräfte · 16 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Jay S. Duker | President and CEO | 10. Juli 2026 M | 9.594 | 0 | 0 | $0 |
| Nancy Lurker | President & CEO | 12. Oktober 2018 A | 211.700 | 0 | 0 | $0 |
| Paul Ashton | President & CEO | 18. März 2016 M | 450.741 | 0 | 0 | $0 |
| David Price | Chief Financial Officer | 1. August 2018 A | — | 0 | 0 | $0 |
| Michael Soja | VP Finance, CFO & Treasurer | 10. September 2008 A | — | 0 | 0 | $0 |
| Ramiro Ribeiro | Chief Medical Officer | 30. Juni 2026 M | 0 | 0 | 2 | $-73.174 |
| Leonard S Ross | Vice President of Finance and Chief Accounting Officer | 22. Dezember 2018 M | 76.187 | 0 | 0 | $0 |
| Dario A. Paggiarino | Chief Medical Officer | 12. Oktober 2018 F | 29.600 | 0 | 0 | $0 |
| Leonard M Blum | Executive VP and General Manager, US | 14. Mai 2018 A | — | 0 | 0 | $0 |
| Debora Jorn | EVP, Corp. & Comm'l Dev. | 27. Juni 2017 A | — | 0 | 0 | $0 |
| Lori Freedman | VP Corporate Affairs, General Counsel and Secretary | 21. Juli 2016 A | 96.423 | 0 | 0 | $0 |
| Aaron Finlay | Secretary | 18. Oktober 2007 A | — | 0 | 0 | $0 |
| Karen L. Zaderej | Direktor | 18. August 2026 P | 49.100 | 1 | 0 | $52.258 |
| Wendy F Dicicco | Direktor | 2. Januar 2026 A | — | 0 | 0 | $0 |
| ANDO GORAN | Direktor | 2. Januar 2026 A | — | 0 | 0 | $0 |
| Fred Hassan | Direktor | 2. Januar 2026 A | — | 0 | 0 | $0 |
| Michael W Rogers | Direktor | 15. November 2018 M | 112.500 | 0 | 0 | $0 |
| John B. Landis | Direktor | 25. Oktober 2018 A | — | 0 | 0 | $0 |
| David J Mazzo | Direktor | 6. September 2018 A | 138.000 | 0 | 0 | $0 |
| Douglas Evan Godshall | Direktor | 27. Juni 2018 M | 12.500 | 0 | 0 | $0 |
| James J Barry | Direktor | 7. Mai 2018 M | 12.500 | 0 | 0 | $0 |
| Kristine Peterson | Direktor | 15. Dezember 2017 A | — | 0 | 0 | $0 |
| SAVAS PETER G | Direktor | 3. Dezember 2015 A | — | 0 | 0 | $0 |
| Paul Hopper | Direktor | 18. Dezember 2013 A | 10.000 | 0 | 0 | $0 |
| Katherine Woodthorpe | Direktor | 27. November 2007 A | — | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
Aktivisten & 5%+-Eigentümer 5 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| EW Healthcare Partners L.P., EW Healthcare Partners-A L.P., Essex Woodlands Fund IX-GP, L.P., Essex Woodlands IX, LLC, Martin P. Sutter, R. Scott Barry, Ronald Eastman, Petri Vainio, Steve Wiggins ×4 Einreichungen | 8. Dezember 2023 | — | Erste Einreichung | — | SEC |
| Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter | 30. August 2023 | — | Erste Einreichung | — | SEC |
| Ocumension Therapeutics | 22. Januar 2021 | — | Erste Einreichung | — | SEC |
| IRS Identification Nos. of above persons (entities only) Pfizer Inc. ×2 Einreichungen | 26. Mai 2017 | — | Erste Einreichung | — | SEC |
| Pfizer Inc. | 17. Juli 2007 | — | Erste Einreichung | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF-Besitz Gehalten von 42 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| PILL · Direxion Shares ETF Trust | 1,18% | 11.564 NS | 30. April 2026 | N-PORT |
| BBC · ETFis Series Trust I | 0,61% | 17.260 NS | 30. April 2026 | N-PORT |
| FSCC · Federated Hermes ETF Trust | 0,12% | 25.180 NS | 31. Mai 2026 | N-PORT |
| NUSC · Nushares ETF Trust | 0,08% | 78.250 NS | 30. April 2026 | N-PORT |
| BIB · ProShares Trust | 0,06% | 3.062 NS | 31. Mai 2026 | N-PORT |
| GSSC · Goldman Sachs ETF Trust | 0,04% | 25.575 NS | 31. Mai 2026 | N-PORT |
| RSSL · Global X Funds | 0,03% | 33.518 NS | 30. April 2026 | N-PORT |
| ITWO · ProShares Trust | 0,03% | 3.648 NS | 31. Mai 2026 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0,02% | 378.469 NS | 31. Mai 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0,02% | 34.174 NS | 30. April 2026 | N-PORT |
| UWM · ProShares Trust | 0,02% | 2.853 NS | 31. Mai 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,01% | 152.391 NS | 30. April 2026 | N-PORT |
| URTY · ProShares Trust | 0,01% | 2.885 NS | 31. Mai 2026 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,01% | 2.895 NS | 31. Mai 2026 | N-PORT |
| HDG · ProShares Trust | 0,00% | 72 NS | 31. Mai 2026 | N-PORT |
| ONEQ · Fidelity Commonwealth Trust | 0,00% | 28.026 NS | 31. Mai 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 3.564 NS | 30. April 2026 | N-PORT |
| SCHB · SCHWAB STRATEGIC TRUST | 0,00% | 46.188 NS | 31. Mai 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 10.667 NS | 30. April 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,00% | 41.879 NS | 30. April 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,00% | 13.282 NS | 30. April 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | — | — | 15. Juli 2026 | Täglich |
| VTI · VANGUARD INDEX FUNDS | — | — | 15. Juli 2026 | Täglich |
| VFMO · VANGUARD WELLINGTON FUND | — | — | 30. Juli 2026 | Täglich |
| VTWO · VANGUARD SCOTTSDALE FUNDS | — | — | 15. Juli 2026 | Täglich |
| VTWV · VANGUARD SCOTTSDALE FUNDS | — | — | 15. Juli 2026 | Täglich |
| VTWG · VANGUARD SCOTTSDALE FUNDS | — | — | 15. Juli 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | — | — | 15. Juli 2026 | Täglich |
| ITOT · iShares Trust | — | — | 22. Juli 2026 | Täglich |
| IWV · iShares Trust | — | — | 18. August 2026 | Täglich |
| IWN · iShares Trust | — | — | 17. August 2026 | Täglich |
| IWO · iShares Trust | — | — | 18. August 2026 | Täglich |
| IWM · iShares Trust | — | — | 18. August 2026 | Täglich |
| IWC · iShares Trust | — | — | 18. August 2026 | Täglich |
| IHE · iShares Trust | — | — | 18. August 2026 | Täglich |
| PRFZ · Invesco Exchange-Traded Fund Trust | — | — | 13. Juli 2026 | Täglich |
| VHT · VANGUARD WORLD FUND | — | — | 20. Juli 2026 | Täglich |
| ISCB · iShares Trust | — | — | 20. Juli 2026 | Täglich |
| ISCV · iShares Trust | — | — | 20. Juli 2026 | Täglich |
| WSML · iShares Trust | — | — | 20. Juli 2026 | Täglich |
| IBBQ · Invesco Exchange-Traded Fund Trust … | — | — | 20. Juli 2026 | Täglich |
| QQQS · Invesco Exchange-Traded Fund Trust … | — | — | 5. August 2026 | Täglich |